Xeris Biopharma Holdings, Inc. XERS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $554K+101% | -$54.84M+11.9% | -$62.26M+34.2% | -$94.66M+22.9% | ||
| $1.31M+7.0% | $1.23M-17.5% | $1.49M+6.3% | $1.4M+5.3% | ||
| $22.37M+21.8% | $18.36M+71.4% | $10.72M-11.9% | $12.16M+6.8% | ||
| $3.31M+10.4% | $3M+31.7% | $2.28M+45.2% | $1.57M+63.1% | ||
| —— | —— | —— | $13.37M+100% | ||
| $19.29M+120% | $8.78M-40.7% | $14.8M+98.3% | $7.47M+0.6% | ||
| -$69K— | —— | $7.31M— | —— | ||
| —— | $3.65M— | —— | —— | ||
| $3.99M+472% | -$1.07M-130% | $3.63M+44.9% | $2.51M+311% | ||
| $0-100% | $83K-74.1% | $320K— | —— | ||
| —— | —— | -$3.21M-182% | $3.89M+218% | ||
| $10.84M0.0% | $10.84M0.0% | $10.84M0.0% | $10.84M+1,871% | ||
| $537K-3.2% | $555K-33.1% | $830K+94.8% | $426K— | ||
| -$1.58M— | —— | $7.54M+938% | -$899K— | ||
| $28.63M+173% | -$38.96M— | —— | -$102.89M-7.7% | ||
| -$696K— | —— | —— | $34.46M-64.8% | ||
| $11.58M— | —— | $0— | —— | ||
| $10.88M+191% | $3.73M+270% | $1.01M+116% | $468K— | ||
| —— | $36.25M— | —— | $127.66M+369% | ||
| $39.32M+866% | $4.07M— | —— | —— | ||
| $27.12M+0.6% | $26.95M-2.7% | $27.69M+155% | $10.86M+48.9% | ||
| $3.31M+10.4% | $3M+31.7% | $2.28M+45.2% | $1.57M+63.1% | ||
| $10.84M0.0% | $10.84M0.0% | $10.84M0.0% | $10.84M+1,871% | ||
| —— | $4.88M+61.5% | $3.03M— | —— | ||
| —— | $3.92M-26.4% | $5.33M— | —— | ||
| -$1.58M— | —— | $7.54M+938% | -$899K— | ||
| —— | —— | -$3.21M-182% | $3.89M+218% | ||
| $537K-3.2% | $555K-33.1% | $830K+94.8% | $426K— | ||
| -$696K+19.8% | -$868K+61.6% | -$2.26M-332% | -$524K+51.7% | ||
| -$1.58M— | —— | $7.54M+938% | -$899K— | ||
| —— | —— | $0— | —— | ||
| —— | $0— | $0— | —— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xeris Biopharma Holdings, Inc. generate?
- Xeris Biopharma Holdings, Inc. (XERS) generated $48.5M in operating cash flow over the trailing twelve months.
- Where does Xeris Biopharma Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
